Atlas Trials

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma

Clinical trial NCT05323253 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05323253
Sponsor
Alpha Tau Medical LTD.
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Recurrent Squamous Cell Carcinoma
Start date
2022-09-21
Primary completion
2027-04-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.